Rethinking hyperhomocysteinemia: from causal risk factor to biomarker of glutathione deficiency in chronic diseases

Alexey Polonikov

Open source

DOI
10.1080/10408363.2026.2743757
Published
2026-10-20
Container
Critical Reviews in Clinical Laboratory Sciences
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10408363.2026.2743757,
  title = {Rethinking hyperhomocysteinemia: from causal risk factor to biomarker of glutathione deficiency in chronic diseases},
  author = {Alexey Polonikov},
  year = {2026},
  journal = {Critical Reviews in Clinical Laboratory Sciences},
  doi = {10.1080/10408363.2026.2743757},
  url = {https://doi.org/10.1080/10408363.2026.2743757}
}

RIS

TY  - JOUR
TI  - Rethinking hyperhomocysteinemia: from causal risk factor to biomarker of glutathione deficiency in chronic diseases
AU  - Alexey Polonikov
PY  - 2026
JO  - Critical Reviews in Clinical Laboratory Sciences
DO  - 10.1080/10408363.2026.2743757
UR  - https://doi.org/10.1080/10408363.2026.2743757
ER  - 

APA

Polonikov, A. (2026). Rethinking hyperhomocysteinemia: from causal risk factor to biomarker of glutathione deficiency in chronic diseases. Critical Reviews in Clinical Laboratory Sciences. https://doi.org/10.1080/10408363.2026.2743757

Source records